動物用医薬品の調合の世界市場

動物用医薬品の調合の世界市場は2030年までに32億米ドルに到達

2024年に20億米ドルと推定される動物用医薬品の調合の世界市場は、2024年から2030年にかけてCAGR 7.7%で成長し、2030年には32億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるCNS薬剤は、CAGR 7.8%を記録し、分析期間終了時には11億米ドルに達すると予測されます。抗感染症薬セグメントの成長率は、分析期間中CAGR 9.3%と推定されます。

米国市場は5億5,480万米ドルと推定、中国はCAGR12.0％で成長予測

米国の動物用医薬品の調合市場は、2024年に5億5,480万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR12.0％を引きずる形で、2030年までに6億7,690万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.9%と7.4%と予測されています。欧州では、ドイツがCAGR 5.2%で成長すると予測されています。

世界の動物用医薬品の調合市場- 主要動向と促進要因まとめ

なぜペットや家畜の飼い主の間でカスタマイズされた動物用医薬品の需要が高まっているのか？

動物用医薬品の調合（剤形、成分、デリバリー機構を変更し、動物用にカスタマイズした医薬品を調製すること）は、世界的に需要が急増しています。この動向は、ペットの人間化の進展と密接に関連しており、ペットの飼い主は、人間の医療で利用可能なものに匹敵する個別化されたヘルスケアソリューションを求めています。標準的な動物用医薬品は、投与形態や強さが限定されていることが多く、体格や動物種が異なったり、特定の健康状態にある動物には適さないです。調合により、獣医師は犬、猫、馬、エキゾチックペット、さらには家畜を含む多様な動物に合わせた投薬が可能になります。これには、固形の錠剤を風味のある液剤に変えたり、アレルゲンや不活性成分を除去したり、複数の薬剤を1つの剤形に組み合わせて服薬アドヒアランスを改善したりすることが含まれます。関節炎、糖尿病、皮膚疾患といった動物の慢性疾患の増加により、大量生産された薬剤では対応できない特殊な製剤の必要性がさらに強調されています。馬医療では、特定の投与レジメンと嗜好性を必要とする症状を持つパフォーマンスホースの治療において、配合が重要な役割を果たしています。コンパニオンアニマルの飼育が世界的に増加するにつれ、特に北米、欧州、アジア太平洋地域の都市部では、安全で効果的なペット専用の配合剤に対する需要が着実に高まり、動物用医薬品業界における重要な成長チャネルとなっています。

規制状況はどのように動物用調剤の情勢を形成しているか？

動物用医薬品の配合を取り巻く規制の枠組みは急速に進化しており、個別化された動物ケアの利点と安全性および品質保証の必要性のバランスを取ることを目指しています。米国では、食品医薬品局（FDA）は、動物用医薬品のライセンシングが、認可された適切な代替手段が存在しない場合に限り、認可を受けた薬剤師または獣医師によって適切な条件下で調製されることを保証するためのガイダンスを発表しています。FDAのGFI#256のような最近の動向は、原薬から動物用医薬品を調合する際の許容される状況および品質慣行について概説しており、これにより市場が正式になり、ベストプラクティスが奨励されています。同様に、欧州医薬品庁（EMA）やその他の地域の規制機関は、配合された医薬品が定められた安全性と有効性の基準を満たしていることを保証するために、監視を強化しています。医薬品インフラが発展している国々では、十分な動物用医薬品の選択肢がないため、地方政府が農村や農業環境におけるアンメットニーズに対応するため、規制された調合実務を推進しています。適正配合基準（GCP）への準拠と薬局基準の遵守は、動物用調剤薬局とサービスプロバイダーにとって重要な差別化要因になりつつあります。これらの進化する規制は、品質管理を強化する一方で技術革新を促し、最終的に動物用調剤をより広範な動物用医薬品市場の不可欠な一部として合法化し、制度化しています。

市場の多様化を促進する主要セグメントと製剤とは？

動物用医薬品の調合市場は、動物種、剤形、治療カテゴリー、流通モデルにおいて急速に多様化しています。伴侶動物が最大のセグメントを占めており、ペットの飼い主が疼痛管理、不安、ホルモン療法、皮膚科的問題のためにカスタマイズされた薬剤を求めています。家畜や家禽の生産者も、地域特有の病原菌に対処しながら休薬期間のガイドラインを遵守する牛群特有の治療のために、ますます配合薬を利用するようになっています。剤形としては、風味のある経口懸濁液、局所用クリーム、経皮ゲル、チュアブルおやつ、無菌注射剤などが最も需要が高く、コンプライアンスの向上と正確な投与が可能です。獣医皮膚科、眼科、循環器科、腫瘍科は、複雑で多様な治療ニーズがあるため、特に強力な応用分野です。eコマースと遠隔医療も大きな変化を促しており、動物用遠隔医療プラットフォームは調剤薬局と提携して、ペット専用の処方箋を戸別配達しています。フレーバー・マスキング、徐放性製剤、非侵襲的デリバリー・メカニズムにおける革新は、配合薬の実現可能性の限界を押し広げています。さらに、大規模な動物病院や獣医教育機関では、特殊な治療ニーズに迅速に対応するため、院内に調剤ユニットを設置しています。このような開発は、現代的な人間のヘルスケアと同様に、個別化された、迅速な獣医学的ケアへの幅広いシフトを裏付けるものです。

世界の動物用医薬品の調合市場の力強い成長の原動力は？

動物用医薬品の調合市場の成長は、消費者行動の変化、高度な治療需要、分野特有のイノベーションに関連するいくつかの要因によって牽引されています。ペットの飼育率の上昇とコンパニオンアニマルの人間化は、従来の治療を超えた、ペット中心の専門的な投薬ソリューションに対する強い需要を生み出しています。精密計量システム、自動ミキサー、無菌環境など、医薬品配合における技術の進歩は、高品質でスケーラブルなオーダーメイド製剤の製造を可能にしています。最終用途の側では、動物の慢性疾患や加齢に関連した疾患の蔓延が増加しているため、獣医師は、配合によってのみ提供可能な柔軟性のある複数の治療オプションを求めざるを得なくなっています。獣医の遠隔医療とオンラインペット薬局の成長は、遠隔地や十分なサービスを受けていない地域への配合薬の普及を拡大しています。さらに、家畜生産者の間で薬剤耐性や残留管理に対する意識が高まっているため、より的を絞った短期間の治療が調剤によって可能になりつつあります。また、主要市場における規制の改善により、動物用医薬品への投資と技術革新にとってより安全な環境が整いつつあります。ペットの健康のパーソナライゼーションや生産技術から、獣医学的サービスモデルや規制インフラに至るまで、これらすべての要因が総合的に、コンパニオンアニマルおよび畜産動物の両セグメントにおける配合動物用医薬品の世界の普及を加速させています。

セグメント

薬剤クラス（中枢神経系薬剤、抗感染症剤、ホルモン・代用剤、抗炎症剤、その他の薬剤クラス別）;動物の種類（コンパニオンアニマル、家畜動物）;投与経路（経口、注射、その他の投与経路）

調査対象企業の例（全42件）

• Akina Animal Health
• Brava Veterinary Pharmacy
• Central Compounding Center South
• Chewy Inc.
• Covetrus
• Custom Compounding Pharmacy
• Davis Islands Pharmacy & Compounding Lab
• Lorraine's Pharmacy
• Merck Animal Health（MSD Animal Health）
• Miller's Pharmacy
• Mixlab
• Norbrook Laboratories Ltd
• Northwest Compounders
• Pace Pharmacy
• PetMeds
• Pharmaca
• Specialty Veterinary Pharmacy
• Stokes Pharmacy
• The Pet Apothecary
• Triangle Compounding Pharmacy

AI統合

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Veterinary Drugs Compounding Market to Reach US$3.2 Billion by 2030

The global market for Veterinary Drugs Compounding estimated at US$2.0 Billion in the year 2024, is expected to reach US$3.2 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. CNS Agents, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Anti-Infective Agents segment is estimated at 9.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$554.8 Million While China is Forecast to Grow at 12.0% CAGR

The Veterinary Drugs Compounding market in the U.S. is estimated at US$554.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$676.9 Million by the year 2030 trailing a CAGR of 12.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Global Veterinary Drugs Compounding Market - Key Trends & Drivers Summarized

Why Is Customized Veterinary Medication Rising in Demand Among Pet and Livestock Owners?

Veterinary drug compounding-the practice of preparing customized medications for animals by altering dosage forms, ingredients, or delivery mechanisms-is experiencing a strong surge in global demand. This trend is closely linked to the increasing humanization of pets, as pet owners seek personalized healthcare solutions comparable to those available in human medicine. Standard veterinary drugs often come in limited dosage forms or strengths, making them unsuitable for animals of different sizes, species, or with specific health conditions. Compounding allows veterinarians to tailor medication for diverse animals including dogs, cats, horses, exotic pets, and even livestock. This may involve converting solid tablets into flavored liquids, removing allergens or inactive ingredients, or combining multiple drugs into a single dosage form to improve adherence. The rise of chronic diseases in animals, such as arthritis, diabetes, and dermatological disorders, has further emphasized the need for specialized formulations that cannot be met by mass-produced drugs. In equine medicine, compounding plays a vital role in treating performance horses with conditions requiring specific dosing regimens and palatability. As companion animal ownership increases worldwide-particularly in urban regions of North America, Europe, and parts of Asia-Pacific-the demand for safe, effective, and pet-specific compounded drugs is steadily rising, creating a significant growth channel in the veterinary pharmaceutical industry.

How Are Regulatory Developments Shaping the Veterinary Compounding Landscape?

The regulatory framework surrounding veterinary drug compounding is evolving rapidly, aiming to balance the benefits of personalized animal care with the need for safety and quality assurance. In the U.S., the Food and Drug Administration (FDA) has issued guidance to ensure that compounded veterinary drugs are prepared under appropriate conditions by licensed pharmacists or veterinarians and only when no suitable approved alternative exists. Recent developments like the FDA’s GFI #256 outline permissible circumstances and quality practices for animal drug compounding from bulk drug substances, thereby formalizing the market and encouraging best practices. Similarly, the European Medicines Agency (EMA) and other regional regulatory bodies are enhancing oversight to ensure that compounded drugs meet defined safety and efficacy standards. In countries with developing pharmaceutical infrastructure, the lack of sufficient veterinary drug options has prompted local governments to promote regulated compounding practices to address unmet needs in rural and agricultural settings. Compliance with Good Compounding Practices (GCP) and adherence to pharmacopeial standards are becoming key differentiators for veterinary compounding pharmacies and service providers. These evolving regulations are encouraging innovation while reinforcing quality control, ultimately legitimizing and institutionalizing veterinary compounding as an integral part of the broader veterinary pharmaceutical market.

What Are the Key Segments and Formulations Driving Market Diversification?

The veterinary drugs compounding market is diversifying rapidly across species, dosage forms, therapeutic categories, and distribution models. Companion animals represent the largest segment, with pet owners seeking customized medications for pain management, anxiety, hormone therapy, and dermatological issues. Livestock and poultry producers are also increasingly turning to compounded drugs for herd-specific treatments that adhere to withdrawal period guidelines while addressing region-specific pathogens. In terms of dosage forms, flavored oral suspensions, topical creams, transdermal gels, chewable treats, and sterile injectables are among the most in-demand, offering enhanced compliance and precise dosing. Veterinary dermatology, ophthalmology, cardiology, and oncology are particularly strong application areas due to the complex and varied treatment needs they involve. E-commerce and telemedicine are also driving significant change, with veterinary telehealth platforms partnering with compounding pharmacies to offer door-delivered, pet-specific prescriptions. Innovations in flavor masking, extended-release formulations, and non-invasive delivery mechanisms are pushing the boundaries of what compounded medications can achieve. Additionally, large-scale animal hospitals and veterinary teaching institutions are establishing in-house compounding units to meet specialized treatment needs promptly. These developments collectively underscore a broader shift toward individualized, responsive veterinary care that mirrors the standards of modern human healthcare.

What Is Fueling the Strong Growth of the Veterinary Drugs Compounding Market Globally?

The growth in the veterinary drugs compounding market is driven by several factors related to shifting consumer behavior, advanced therapeutic demands, and sector-specific innovations. Rising pet ownership and the humanization of companion animals are creating a strong demand for specialized, pet-centric medication solutions that go beyond conventional treatments. Technological advancements in pharmaceutical compounding-such as precision weighing systems, automated mixers, and sterile environments-are enabling high-quality, scalable production of customized formulations. On the end-use side, the increasing prevalence of chronic and age-related animal diseases is compelling veterinarians to seek out flexible, multi-therapy treatment options that can only be delivered through compounding. The growth of veterinary telemedicine and online pet pharmacies is expanding the reach of compounded medications to remote and underserved regions. Furthermore, heightened awareness among livestock producers regarding drug resistance and residue management is encouraging more targeted, short-duration treatments made possible through compounding. Regulatory refinements in key markets are also creating a more secure environment for investment and innovation in veterinary pharmaceutical services. All these factors-ranging from pet health personalization and production technology to veterinary service models and regulatory infrastructure-are collectively accelerating the global adoption of compounded veterinary drugs across both companion and production animal segments.

SCOPE OF STUDY:

The report analyzes the Veterinary Drugs Compounding market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Drug Class (CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents, Other Drug Classes); Animal Type (Companion Animals, Livestock Animals); Administration Route (Oral, Injectable, Other Administration Routes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Akina Animal Health
• Brava Veterinary Pharmacy
• Central Compounding Center South
• Chewy Inc.
• Covetrus
• Custom Compounding Pharmacy
• Davis Islands Pharmacy & Compounding Lab
• Lorraine's Pharmacy
• Merck Animal Health (MSD Animal Health)
• Miller's Pharmacy
• Mixlab
• Norbrook Laboratories Ltd
• Northwest Compounders
• Pace Pharmacy
• PetMeds
• Pharmaca
• Specialty Veterinary Pharmacy
• Stokes Pharmacy
• The Pet Apothecary
• Triangle Compounding Pharmacy

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Veterinary Drugs Compounding - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growth in Pet Ownership and Livestock Welfare Awareness Drives Compounded Drug Demand
  • Rise in Drug Shortages and Supply Gaps Throws Spotlight on Veterinary Compounding Services
  • Increased Customization Needs for Exotic and Small Animals Spur Market Expansion
  • Advancement in Flavor Masking Technologies Enhances Acceptability of Compounded Medications
  • Aging Pet Population and Chronic Disease Management Accelerate Demand for Tailored Formulations
  • Lack of Dosage Flexibility in Commercial Drugs Expands Opportunity for Compounded Alternatives
  • Growth in Equine and Performance Animal Care Drives Niche Compounding Applications
  • Use of Telemedicine in Veterinary Practices Fuels Growth in Mail-Order Compounded Drugs
  • Compounding for Antimicrobial Stewardship and Antibiotic Alternatives Spurs Innovation
  • Pet Insurance Coverage Expansion Strengthens Market for Custom Veterinary Medications
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Veterinary Drugs Compounding Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Veterinary Drugs Compounding by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Veterinary Drugs Compounding by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for CNS Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for CNS Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for CNS Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Anti-Infective Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Anti-Infective Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Anti-Infective Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Hormones & Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Hormones & Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Hormones & Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Anti-Inflammatory Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Anti-Inflammatory Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Anti-Inflammatory Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Drug Classes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Administration Routes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Injectable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Injectable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Injectable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Companion Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Livestock Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Livestock Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Livestock Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Veterinary Drugs Compounding Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• JAPAN
  • Veterinary Drugs Compounding Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• CHINA
  • Veterinary Drugs Compounding Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• EUROPE
  • Veterinary Drugs Compounding Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Veterinary Drugs Compounding by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Veterinary Drugs Compounding by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• FRANCE
  • Veterinary Drugs Compounding Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• GERMANY
  • Veterinary Drugs Compounding Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Veterinary Drugs Compounding Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Veterinary Drugs Compounding Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Veterinary Drugs Compounding by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Veterinary Drugs Compounding by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Veterinary Drugs Compounding Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• INDIA
  • Veterinary Drugs Compounding Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Veterinary Drugs Compounding Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Veterinary Drugs Compounding by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Veterinary Drugs Compounding by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Veterinary Drugs Compounding Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Veterinary Drugs Compounding by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Veterinary Drugs Compounding by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
• AFRICA
  • Veterinary Drugs Compounding Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Veterinary Drugs Compounding by Drug Class - CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Veterinary Drugs Compounding by Drug Class - Percentage Breakdown of Value Sales for CNS Agents, Anti-Infective Agents, Hormones & Substitutes, Anti-Inflammatory Agents and Other Drug Classes for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Veterinary Drugs Compounding by Administration Route - Other Administration Routes, Oral and Injectable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Veterinary Drugs Compounding by Administration Route - Percentage Breakdown of Value Sales for Other Administration Routes, Oral and Injectable for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Veterinary Drugs Compounding by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Veterinary Drugs Compounding by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030

IV. COMPETITION